An Active Safety Surveillance Using Real-World Evidence (ASSURE) Approach to Pharmacovigilance Signal Evaluation: The case of infliximab and alternative autoimmune conditions

Authors: Kevin Haynes, Mitchell M. Conover, Jenna Reps, Steven S. Smugar, Robert Suruki

Brief Report